Clorox price target lowered to $114 from $120 at JPMorgan

JPMorgan lowered the firm’s price target on Clorox (CLX) to $114 from $120 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the beverage, household and personal care products group as part of its Q4 earnings preview. JPMorgan believes the sector setup into earnings remains mixed, with the “most plain vanilla companies” and with those with the most exposure to the U.S. consumer likely to post “lackluster” sales. The stocks exposed to beauty and companies that focus on “differentiated and innovative premium products” should continue to outperform, the analyst tells investors in a research note.